Formation Venture Engineering is a Boston-based venture capital firm founded in 2018, specializing in the life sciences sector. The firm focuses on nurturing emerging technologies by investing in and building around game-changing innovations, with a strategic emphasis on identifying potential acquirers early in the process. This approach aims to engineer companies toward accelerated exits, thereby reducing human suffering and creating financial value.

The firm's methodology includes aligning with acquirers for rapid scaling, assembling teams from industry leaders, and ensuring operational excellence to deliver uncommon value to entrepreneurs, investors, and the global community. Notable portfolio companies include Cell IDx, which was acquired by Leica Biosystems in November 2022, demonstrating the firm's successful execution of its venture engineering model.